Your session is about to expire
← Back to Search
ONO-2020 for Healthy Participants
Study Summary
This trial is testing a new drug to see if it is safe and tolerated by healthy adults, including elderly and Japanese participants. They will also study how the new drug is affected by food.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Are there any current opportunities for patients to join this experiment?
"Indeed, the details of this clinical trial are currently being hosted on clinicaltrials.gov. It was initially posted on July 29th 2022 and has been refreshed as recently as August 16th 2022. 138 participants must be enrolled from a single location for this study to move forward."
Has ONO-2020 been given permission from the FDA to be used in treatments?
"Due to the limited evidence of efficacy and safety, ONO-2020 is judged to be a 1 on our Risk Scale. This assessment reflects that it is in Phase 1 of clinical trials."
How many participants can this experiment accommodate at maximum capacity?
"Affirmative. According to the clinicaltrials.gov listing, this experiment is currently attempting to find 138 individuals at one site. This trial was initially posted on July 29th 2022 and has been updated as of August 16th 2022."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger